Skip to main content
Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
2.680
-0.040 (-1.47%)
At close: Nov 20, 2024, 4:00 PM
2.720
+0.040 (1.49%)
After-hours: Nov 20, 2024, 7:20 PM EST

Absci Revenue

Absci had revenue of $1.70M in the quarter ending September 30, 2024, with 128.63% growth. This brings the company's revenue in the last twelve months to $4.21M, down -39.35% year-over-year. In the year 2023, Absci had annual revenue of $5.72M, down -0.50%.

Revenue (ttm)
$4.21M
Revenue Growth
-39.35%
P/S Ratio
66.66
Revenue / Employee
$27,142
Employees
155
Market Cap
307.81M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20235.72M-29.00K-0.50%
Dec 31, 20225.75M965.00K20.18%
Dec 31, 20214.78M2.00K0.04%
Dec 31, 20204.78M2.72M132.04%
Dec 31, 20192.06M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cerus 176.23M
Codexis 64.45M
AVITA Medical 60.04M
AC Immune 48.51M
Delcath Systems 22.64M
Nyxoah 5.67M
Lexicon Pharmaceuticals 5.23M
Lyell Immunopharma 63.00K
Revenue Rankings

ABSI News

More News